跳至主要内容
临床试验/NCT05398250
NCT05398250Enrolling By Invitation不适用

A Comparison of Two Brief Suicide Prevention Interventions Tailored for Youth on the Autism Spectrum

University of North Carolina, Chapel Hill5 个研究点 分布在 1 个国家目标入组 1,665 人开始时间: 2022年8月23日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
1,665
试验地点
5
主要终点
Change in suicidal ideation and behavior

研究概览

简要总结

Rates of suicide have increased significantly over the past two decades, particularly among youth. Compared to the general population, autistic people are significantly more likely to think about suicide, attempt suicide, and die by suicide. Autistic individuals have identified suicide prevention as a top research priority; however, little is known about how to best help autistic youth at risk for suicide. The purpose of this study is to compare the effectiveness, feasibility, and acceptability of two suicide prevention strategies tailored for autistic individuals: the Safety Planning Intervention tailored for Autistic individuals (SPI-A) and SPI-A plus structured follow-up contacts (SPI-A+).

详细描述

**Participants**

Participants are from three distinct groups: health systems leaders, clinicians, and autistic youth (patients). The autistic youth participant pool is comprised of three subgroups, described below.

  1. "Basic EHR-Only" Arm:

Population: All individuals 12-24yo scheduled for a clinical visit with a consented clinician during the study recruitment period qualify for this arm. The total number of subjects for this subgroup is expected to exceed 15k individuals.

Participation is limited to Electronic Health Record (EHR) review only. Participants will not have contact with the study team. 2. "Enhanced EHR-Only" Arm: Population: Individuals meeting the above criteria who also receive one of the interventions of interest (SPI-A or SPI-A+) during routine clinical care. Approximately 250-400 individuals are expected to qualify for this arm.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
12 Years 至 99 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • (A) Patient Participants
  • Please note that that eligibility criteria differ for each distinct patient subgroup as defined below.
  • A.1 - Basic EHR-Only Arm
  • Inclusion criteria:
  • 12-24 years old
  • Scheduled for a clinical visit with a consented clinician

排除标准

  • A.2 - Enhanced EHR-Only Arm:
  • Inclusion criteria:
  • Meets inclusion criteria for the Basic EHR-Only arm
  • Receives one of the interventions being studied (SPI-A or SPI-A+) as part of routine clinical care
  • Exclusion criteria: Presence of documentation that the patient declines all research participation
  • A.3 - Active PRO Arm:
  • Inclusion Criteria:
  • Meets inclusion criteria for the Enhanced EHR-Only arm
  • Referred to the study team by a consented clinician
  • Able and willing to provide informed consent (age 18+) or assent and parental/guardian consent (age < 18)
  • Able to speak English (and, if applicable, at least one guardian also able to speak English)
  • Exclusion Criteria: Altered mental status that precludes ability to provide informed assent or consent (acute psychosis, intoxication, or mania)
  • (B) Clinician Participants
  • Inclusion Criteria:
  • Employment as a provider serving autistic patients at one of the study sites
  • Employment in a role that involves suicide risk intervention with youth patients at a participating clinic
  • Able to read and speak English
  • Able and willing to provide informed consent
  • Exclusion Criteria: None
  • (C) Health System Leader Participants
  • Inclusion Criteria:
  • Health system or clinic leader at one of the study sites
  • Employed in a role that provides administrative oversight to clinicians conducting safety plans with patients
  • Able to read and speak English
  • Able and willing to provide informed consent
  • Exclusion Criteria: None

研究组 & 干预措施

Safety Planning Intervention Tailored for Autistic Individuals

Active Comparator

The Safety Planning Intervention Tailored for Autistic individuals (SPI-A) is a brief collaborative intervention that results in an individually tailored plan designed to lower the short-term risk of suicide in autistic youth.

干预措施: Safety Planning Intervention tailored for Autistic Individuals (Behavioral)

Safety Planning Intervention Tailored for Autistic Individuals Plus Structured Follow-Up Contacts

Active Comparator

The Safety Planning Intervention Tailored for Autistic individuals plus structured follow-up contacts (SPI-A+) is a multi-component intervention comprised of SPI-A and structured follow-up consisting of at least 2 brief contacts.

干预措施: Safety Planning Intervention Tailored for Autistic Individuals Plus Structured Follow-Up Contacts (Behavioral)

结局指标

主要结局

Change in suicidal ideation and behavior

时间窗: Through 12 months of follow-up

The Columbia-Suicide Severity Rating Scale (C-SSRS) is a clinical interview that measures suicidal ideation (range 0-5, with higher scores indicating more severe ideation) and suicidal behavior (count of total number of actual attempts, interrupted attempts, aborted attempts, and preparatory acts or behavior). The C-SSRS will be administered at baseline, 1-month follow-up, 6-month follow-up, and 12-month follow-up.

次要结局

  • Change in mental health treatment utilization(Up to 12 months)
  • Change in quality of life(Up to 12 months)
  • Intervention acceptability(Patient Participants: 1-month follow-up; Clinician and Health System Leader Participants: up to 4 years)
  • Intervention feasibility(Patient Participants: 1-month follow-up; Clinician and Health System Leader Participants: up to 4 years)
  • Change in well-being(Up to 12 months)
  • Change in acute care services for suicidality(Up to 12 months)
  • Change in skills to manage suicidal ideation(Up to 12 months)
  • Change in access to lethal means(Up to 12 months)
  • Change in safety plan use(Up to 12 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验

A Comparison of Two Brief Suicide Prevention... | 临床试验